The Economic Impact of Levothyroxine Dose Adjustments: the CONTROL HE Study. - Wikidata - awgldk - TriplyDB

The Economic Impact of Levothyroxine Dose Adjustments: the CONTROL HE Study.

The Economic Impact of Levothyroxine Dose Adjustments: the CONTROL HE Study.

http://www.wikidata.org/entity/Q37553515

about

Diagnosis and management of treatment-refractory hypothyroidism: an expert consensus report.Levothyroxine Therapy: Changes of TSH Levels by Switching Patients from Tablet to Liquid Formulation. A Systematic Review and Meta-Analysis.Concurrent Milk Ingestion Decreases Absorption of Levothyroxine.

P2860

Q39427728-28A9622D-A634-432D-B185-EB2131B3416F Q49531385-6384AD54-9055-4790-8CA8-F144ACED136C Q52625774-81AD3A6B-F1AF-434D-8411-7209AB678CFF

P2860

The Economic Impact of Levothyroxine Dose Adjustments: the CONTROL HE Study.

http://www.wikidata.org/entity/Q37553515

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 31 October 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The Economic Impact of Levothyroxine Dose Adjustments: the CONTROL HE Study.

@en

The Economic Impact of Levothyroxine Dose Adjustments: the CONTROL HE Study.

@nl

type

label

The Economic Impact of Levothyroxine Dose Adjustments: the CONTROL HE Study.

@en

The Economic Impact of Levothyroxine Dose Adjustments: the CONTROL HE Study.

@nl

prefLabel

The Economic Impact of Levothyroxine Dose Adjustments: the CONTROL HE Study.

@en

The Economic Impact of Levothyroxine Dose Adjustments: the CONTROL HE Study.

@nl

P1433

Q37553515-94FAAFDE-CDC1-4B37-99E4-5D25A71C396F

P1476

Q37553515-BF956390-5609-43E2-A737-D0D389BD987B

P2093

Q37553515-269116BB-7BE0-4C87-869E-2C3C2B13BF36

Q37553515-3408F0AB-33E9-424A-979F-B405D9DB6C3E

Q37553515-35D2A82A-09C2-4AE8-AE4D-C7CAB9531C16

Q37553515-3A9BAE60-034B-45B7-953A-31E8F250A8AC

Q37553515-5706E8BA-3BA5-4492-879B-3144C6BE34D7

Q37553515-8FA4B600-092D-4A3E-9CD8-2182EDF4F36C

Q37553515-B7DCA7D2-FD07-4A69-91CE-5392C8167481

Q37553515-C1FCB093-54F1-4F59-8CB2-E3F69ED10448

P2860

Q37553515-00547448-9D53-4A8D-B899-E0497746BE89

Q37553515-048EC788-B733-471E-B9C5-6C1A33E47CFD

Q37553515-0683B25B-D9C9-4E3C-B83F-D54B08AE53DC

Q37553515-23ABA838-4595-47F3-A294-12BB569122E7

Q37553515-28551C0F-0F54-44BD-80DD-F3B9C03F2426

Q37553515-297923A0-8DDD-499A-B1F0-6795FDFEAF1A

Q37553515-31C614D0-FEB7-4A87-8DA4-76E2318FFC75

Q37553515-335F61E3-7766-4655-86AE-803C711BFA05

Q37553515-38CBEEA0-C3A7-4334-AE67-1AB6D834087B

Q37553515-394D4A73-CF4F-4395-8668-C5268888273C

P304

Q37553515-A2C337A3-7764-4310-B4E9-3C6B41D0BD8C

P31

Q37553515-2B24CEF5-A920-447D-943F-2B55BCCA0DCF

P356

Q37553515-35DBA40A-2178-4523-AC3D-7131B3C47C09

P433

Q37553515-66300E9B-2636-455E-9760-545874EEC7A3

P478

Q37553515-3E11D8DF-17F0-4C23-AFFA-3A27550FFC7E

P577

Q37553515-623DDBED-D215-4BB8-AF1A-A380686B403A

P698

Q37553515-CF4FD87C-F4B5-4DC5-8DD8-D8FAD2A425DC

P932

Q37553515-2ECC1FB4-68F3-440A-B0CB-7D621C61DE29

P356

S40261-016-0462-3

P1433

Clinical Drug Investigation

P1476

The Economic Impact of Levothyroxine Dose Adjustments: the CONTROL HE Study.

@en

P2093

Arnold B Sterman

http://www.w3.org/2001/XMLSchema#string

Frank R Ernst

http://www.w3.org/2001/XMLSchema#string

Jessica Goldenberg

http://www.w3.org/2001/XMLSchema#string

Kevin Vora

http://www.w3.org/2001/XMLSchema#string

Lionel Thevathasan

http://www.w3.org/2001/XMLSchema#string

Peri Barr

http://www.w3.org/2001/XMLSchema#string

Riad Elmor

http://www.w3.org/2001/XMLSchema#string

Walter Sandulli

http://www.w3.org/2001/XMLSchema#string

P2860

Overt and Subclinical Hypothyroidism

Levothyroxine absorption in health and disease, and new therapeutic perspectives

Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association

Clinical practice. Celiac disease

How good is the levothyroxine replacement in primary hypothyroidism patients in Brazil? Data of a multicentre study.

Perspectives on gastroesophageal reflux disease in primary care: the REFLEX study of patient-physician agreement.

The Colorado thyroid disease prevalence study.

Diagnosis and treatment of gastroesophageal reflux disease.

Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).

Hypothyroidism: an update.

P304

71-83

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40261-016-0462-3

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P577

2016-10-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27798756

http://www.w3.org/2001/XMLSchema#string

P932

5209418

http://www.w3.org/2001/XMLSchema#string